These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 1356560)

  • 1. The effects of combined angiotensin converting enzyme inhibition and beta-adrenoceptor blockade on plasma renin activity in anaesthetized dogs.
    Cambridge D; Whiting MV; Butterfield LJ; Allan G
    Br J Pharmacol; 1992 Jun; 106(2):342-7. PubMed ID: 1356560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties.
    Cambridge D; Whiting MV; Allan G
    Br J Pharmacol; 1988 Jan; 93(1):165-75. PubMed ID: 2894874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.
    Ajayi AA; Sofowora GG; Adigun AQ; Asiyanbola B
    Ethn Dis; 2003; 13(1):71-9. PubMed ID: 12723015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Squire IB; MacFayden RJ; Reid JL; Devlin A; Lees KR
    J Cardiovasc Pharmacol; 1996 May; 27(5):657-66. PubMed ID: 8859935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan.
    Hajj-Ali AF; Wong PC
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1423-7. PubMed ID: 7903389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats.
    Schiffrin EL; Gutkowska J; Thibault G; Genest J
    Can J Physiol Pharmacol; 1984 Jan; 62(1):116-23. PubMed ID: 6143602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
    Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the actions of the angiotensin-converting enzyme inhibitors enalapril and S-9490-3 in sodium-deplete and sodium-replete spontaneously hypertensive rats.
    DiNicolantonio R; Doyle AE
    J Cardiovasc Pharmacol; 1985; 7(5):937-42. PubMed ID: 2413304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats.
    Ménard J; Campbell DJ; Azizi M; Gonzales MF
    Circulation; 1997 Nov; 96(9):3072-8. PubMed ID: 9386177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ACE inhibition and beta-blockade on collagen remodelling in the heart of Bio 14.6 hamsters.
    Mansoor AM; Honda M; Kuramochi T; Tanaka K; Morioka S; Takabatake T
    Clin Exp Pharmacol Physiol; 1996 Jan; 23(1):43-9. PubMed ID: 8713495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism and pressor relevance of the short-term cardiovascular and renin excitatory actions of the selective A2A-adenosine receptor agonists.
    Alberti C; Monopoli A; Casati C; Forlani A; Sala C; Nador B; Ongini E; Morganti A
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):320-4. PubMed ID: 9300315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta-adrenoceptor antagonist and angiotensin-converting enzyme inhibitor on hypertension-associated changes in adenylyl cyclase type V messenger RNA expression in spontaneously hypertensive rats.
    Fujino T; Hasebe N; Kawabe J; Fujita M; Fukuzawa J; Tobise K; Kikuchi K
    J Cardiovasc Pharmacol; 2003 May; 41(5):720-5. PubMed ID: 12717102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beta-adrenoceptor controlling renin release.
    Oates HF; Stoker LM; Monaghan JC; Stokes GS
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):205-13. PubMed ID: 213037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of YM-16151-4: a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent in rats and dogs.
    Uchida W; Shibasaki K; Matsuda Y; Asano M; Takenaka T
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):247-52. PubMed ID: 7692165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BW A575C, a chemically novel agent with angiotensin converting enzyme inhibitor and beta-adrenoceptor-blocking properties.
    Allan G; Cambridge D; Hardy GW; Follenfant MJ
    Br J Pharmacol; 1987 Mar; 90(3):609-15. PubMed ID: 2882805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol.
    Czendlik CH; Sioufi A; Preiswerk G; Howald H
    Eur J Clin Pharmacol; 1997; 52(6):451-9. PubMed ID: 9342580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension.
    Teeuw AH; Leenen FH; Geyskes GG; Boer P
    Clin Pharmacol Ther; 1979 Mar; 25(3):294-302. PubMed ID: 367678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers.
    Hansen EF; Bendtsen F; Henriksen JH
    Pharmacol Toxicol; 1999 Mar; 84(3):110-4. PubMed ID: 10193670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.